Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor
Open Access
- 1 December 2017
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 10 (6) , 895-903
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging†Neuro-Oncology, 2013
- Comparison of DSC‐MRI post‐processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBMJournal of Magnetic Resonance Imaging, 2012
- Choline metabolism in malignant transformationNature Reviews Cancer, 2011
- Semi‐parametric time‐domain quantification of HR‐MAS data from prostate tissueNMR in Biomedicine, 2010
- Implementation of 3 T Lactate-Edited 3D 1H MR Spectroscopic Imaging with Flyback Echo-Planar Readout for Gliomas PatientsAnnals of Biomedical Engineering, 2010
- Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBMNeuro-Oncology, 2010
- EditorialNMR in Biomedicine, 2010
- Primer on gadolinium chemistryJournal of Magnetic Resonance Imaging, 2009
- Evaluation of the ERETIC method as an improved quantitative reference for 1H HR‐MAS spectroscopy of prostate tissueMagnetic Resonance in Medicine, 2009
- Which pulse sequence is optimal for myo‐inositol detection at 3T?NMR in Biomedicine, 2008